Palacios, R., Patiño, E.G., Piorelli, R. de O., Conde, M.T.R.P., Batista, A.P., Zeng, G., Xin, Q., Kallas, E.G., Flores, J., Ockenhouse, C.F. and Gast, C. (2020) Double-Blind, Randomized, PlaceboControlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of Treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac—PROFISCOV: A Structured Summary of a Study Protocol for a Randomised Controlled Trial. Clinical Trial, 21, 853.
https://doi.org/10.1186/s13063-020-04775-4

has been cited by the following article:

• TITLE: Benign Fasciculation Syndrome Developing after COVID Vaccine (Sinovac/CoronaVac)

  AUTHORS: Buket Özkara Yılmaz

  KEYWORDS: Fasciculation, COVID, Vaccine

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.11 No.6, June 8, 2022

  ABSTRACT: Benign fasciculation Syndrome (BFS) is related with anxiety level; it is known as fasciculation anxiety syndrome. It may also be caused by long-term use of steroid or anticholinergic, as well as nicotine, caffeine, alcohol, and exposure to insecticides and pesticides. This paper presents a benign fasciculation syndrome case developing after CoronaVac vaccination.